ArticleNaunyn-Schmiedeberg's archives of pharmacology2026

A real-world disproportionality analysis of dupilumab safety in children aged 0-5 years with atopic dermatitis.

Liang Yan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.